Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000884969 | SCV001028381 | benign | not provided | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501414 | SCV002807200 | likely benign | Metabolic myopathy due to lactate transporter defect; Exercise-induced hyperinsulinism; Ketoacidosis due to monocarboxylate transporter-1 deficiency | 2021-09-09 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000884969 | SCV004563830 | likely benign | not provided | 2023-08-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004550027 | SCV004721933 | benign | SLC16A1-related disorder | 2019-12-10 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Breakthrough Genomics, |
RCV000884969 | SCV005280402 | benign | not provided | criteria provided, single submitter | not provided |